[Use of tramal for prevention of motor hyperactivity during r fiber bronchoscopy in patients in the postoperative period].
The efficacy of tramal for preventing motor hyperactivity is assessed in patients on spontaneous respiration after surgery during fiber bronchoscopy under a short-acting hypnotic ethomidate. Group 1 consisted of 22 patients to whom 100 mg of tramal was injected intravenously 30 min before fiber bronchoscopy, group 2 of 10 patients subjected to fiber bronchoscopy without preliminary tramal. Ethomidate caused manifest 20-45-sec myoclonus in the distal parts of the upper and lower limbs in 80% of cases. Pretreatment with tramal (100 mg intravenously) decreased the severity and incidence of myoclonus to 18.2%, did not affect gas exchange, and stabilized hemodynamics during fiber bronchoscopy.
R N
RN
Lebedeva
V I
VI
Brusin
R B
RB
Maiachkin
D000293:Adolescent; D000328:Adult; D000368:Aged; D000701:Analgesics, Opioid / Q000627:therapeutic use*; D018686:Anesthetics, Intravenous / Q000627:therapeutic use; D001999:Bronchoscopy / Q000009:adverse effects*; D005045:Etomidate / Q000627:therapeutic use; D005336:Fiber Optic Technology; D006439:Hemodynamics; D006801:Humans; D006993:Hypnotics and Sedatives / Q000627:therapeutic use; D007866:Leg; D008875:Middle Aged; D009207:Myoclonus / Q000209:etiology / Q000517:prevention & control*; D011184:Postoperative Period; D011659:Pulmonary Gas Exchange; D014147:Tramadol / Q000627:therapeutic use*
D000701:Analgesics, Opioid; D018686:Anesthetics, Intravenous; D006993:Hypnotics and Sedatives; D014147:Tramadol; D005045:Etomidate